Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 5/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL462922 | 0.81 | CYP2C19 (0.46) | PTGS1PTGS2CYP2C19GSK3AGSK3B | |
| Hydrochloric Acid SCHEMBL14765289 | 0.81 | CA12 (0.32) | PTGS1PTGS2MMP1CETPFAAH | |
| SCHEMBL8682479 | 0.76 | MGLL (0.34) | PTGS1PTGS2CYP2C19GSK3AGSK3B | |
| SCHEMBL4655509 | 0.76 | ALDH1A1 (0.33) | PTGS1PTGS2CYP2C19GSK3AGSK3B | |
| SCHEMBL7262379 | 0.75 | CETP (0.38) | PTGS1PTGS2CYP2C19CETPFAAH | |
| SCHEMBL3680694 | 0.73 | ALDH1A1 (0.39) | KMT2A | |
| SCHEMBL28600387 | 0.71 | ALDH1A1 (0.38) | PTGS1PTGS2CYP2C19GSK3AGSK3B | |
| SCHEMBL2157172 | 0.69 | MGLL (0.31) | CYP2C19MGLL | |
| SCHEMBL9561805 | 0.68 | MGLL (0.39) | PTGS1PTGS2CYP2C19GSK3AGSK3B | |
| SCHEMBL9841169 | 0.68 | PTGS1 (0.37) | PTGS1PTGS2CYP2C19GSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11576876-B2 | Affinity Medicant Conjugate | AF CHEMICALS, LLC (US) | 2023-02-14 | — | — | US | disclosed |
| US-20220133649-A1 | AFFINITY MEDICANT CONJUGATE | Califia Pharma Inc. (US) | 2022-05-05 | — | — | US | disclosed |
| US-20210299063-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299063-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | PTGS1 2728/4885PTGS2 3312/4885ADRB2 1492/4885 |
| US-20220133649-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | PTGS1 2728/4885PTGS2 3312/4885ADRB2 1492/4885 |
| US-11576876-B2 | Affinity Medicant Conjugate | FCER2, HDGF, FCGR2A | PTGS1 2728/4885PTGS2 3312/4885ADRB2 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.